Your cart is empty

KISS1 Receptor Research Peptide
Kisspeptin-10 is a short peptide fragment studied in laboratory settings for its role in regulating reproductive hormone signaling pathways. Research commonly examines its influence on GnRH activity and downstream endocrine communication within controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.
In scientific literature, kisspeptin-10 is studied in experimental models examining hypothalamic-pituitary signaling pathways, reproductive axis regulation frameworks, and receptor-mediated endocrine signaling under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Kisspeptin-10 represents the biologically active C-terminal fragment of the KISS1 peptide and has been evaluated in research focused on KISS1 receptor interaction and neuroendocrine signaling systems. Experimental studies examine receptor binding dynamics and downstream signaling mechanisms within controlled laboratory environments.
Research publications have explored its interaction with hypothalamic signaling pathways and reproductive regulatory frameworks under preclinical and clinical research conditions.
The KISS1 gene was originally identified in oncology research before its role in neuroendocrine signaling was characterized. Subsequent investigations demonstrated the interaction of kisspeptins with the GPR54 (KISS1R) receptor, leading to expanded research into reproductive and hypothalamic signaling pathways.
Kisspeptin-10 became a commonly studied fragment due to its receptor activity profile in controlled experimental systems.
Laboratory investigations into kisspeptin-10 have focused on KISS1 receptor activation models and neuroendocrine signaling pathways. Research frameworks evaluate receptor-mediated interaction, hypothalamic signaling systems, and endocrine regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 12mg of lyophilized kisspeptin-10. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized peptide. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab 96(12):E1963–E1972.
PubMedCentral and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 16(10):850–858.
PubMedKisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00